
The Weekly Roundup: August 19-23
In case you missed it, this week we had news about Pelage's novel PP405 in phase 2a for androgenetic alopecia, the availability of apremilast in the US for pediatric psoriasis, higher patient adherence with pre-filled risankizumab pens, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our
AI Scribes Part 2: Clinicians Want Better Tools
Health care professionals are recognizing the growing need for advanced technology in modern medical practice.
Protecting Against Malpractice Liability: Insurance As Your First Line of Defense
David Mandell, JD, MBA, stated in the quest to protect against malpractice liability, insurance is certainly the first and most important line of defense.
Q&A: Pelage's Novel PP405 Advances to Phase 2a for Androgenetic Alopecia
Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.
Wearable Sensors Could Revolutionize AD Management
Researchers stated the integration of wearable sensors with AI could potentially revolutionize care for patients with atopic dermatitis.
Study Reveals Unique Protein Profile in Elevai’s Exosomes
Preliminary data suggests that the exosomes could effectively address common skin concerns, including firmness, photodamage, and fine lines.
Several Dermatological Conditions Require Additional Care and Referral to Specialized Medical Institutions
Researchers assessed patterns of referral from a primary dermatological clinic in Japan.
I Used Botulinum Toxin for Migraines—Now I’ve Been Sued
David Goldberg, MD, JD, stated the use of drugs and devices for conditions that are not otherwise indicated is widespread among physicians and is generally not considered experimental or investigational.
In Europe, Individuals With Atopic Dermatitis Face Impairments in Happiness Versus Other Conditions
Patients with AD and psoriasis both report diminished levels of happiness compared to the general population.
Vitiligo Care Personalized for Each Patient: Part 2
Latanya Benjamin, MD, FAAD, reviewed a case study of a 35-year-old woman with a 10-year history of vitiligo and concomitant atopic dermatitis
Apremilast Now Available for Pediatric Use in the US
The availability is notable as it introduces the first oral treatment option for young psoriasis patients.
Weight Change With Isotretinoin Treatment for Acne Vulgaris Not Statistically Significant
At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.
Laser Advancements Transform Skin Rejuvenation
A review found repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.
Assessing Electrical Impedance Dermography as a Tool in Skin Disease Management and Diagnosis
Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.
Clinicians Should Consider Lifestyle Factor Changes Over Time in Acne Vulgaris Treatment, Study Reports
Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.
Dupilumab's Ocular AEs Higher in AD Patients Than Asthma
The study found 95.8% of ocular AEs occurred in AD patients, while SA patients reported only 4.2% of these events.
Journal Digest: August 21
This week’s collection of the latest dermatologic studies includes the prevalence of vulvar dermatoses among ethnically diverse patients, the adaptation of the Mackie melanoma risk stratification tool into a tablet-based patient questionnaire, siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.
New Report Highlights Health Disparities in Psoriasis Care
The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.
Vitiligo Care Personalized for Each Patient: Part 3
Anthony Nuara, MD, PhD, reviewed a case study of a 32-year-old professional makeup artist who was concerned about her depigmented patches affecting her livelihood.
Significant Disparities Persist in Cutaneous Presentations, Diagnosis, and Outcomes of Scleroderma in Skin of Color
In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.
Case Report Demonstrates Treatment of Refractory Follicular Lichen Planus With Ruxolitinib
After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.
New Toolkit Aims to Boost Diversity in Skin Research
Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.
Daily Collagen Intake Delays Visible Signs of Skin and Nail Aging
A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.
Surgery Exhibits Superior Efficacy for Cutaneous Squamous Cell Carcinoma In Situ
A comprehensive analysis of 71 studies revealed the highest lesion clearance and recurrence rates among individuals who had undergone surgery.
Higher Risankizumab Adherence with New Injection Device
A recent study found prefilled pens with concealed needles showed promise in reducing injection-related anxiety and improving patient adherence.
GLP-1 Agonists Not Linked to the Development of Acne
Acne vulgaris has been reported as an adverse effect of GLP-1 receptor agonists by some patients.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















